Zobrazeno 1 - 10
of 366
pro vyhledávání: '"chronic hepatitis b (chb)"'
Autor:
Lina Wu, Jiadi Lai, Qiumin Luo, Yeqiong Zhang, Chaoshuang Lin, Dongying Xie, Youming Chen, Hong Deng, Zhiliang Gao, Liang Peng, Wenxiong Xu
Publikováno v:
Liver Research, Vol 8, Iss 3, Pp 179-187 (2024)
Background and aim: Few studies have reported hepatitis B surface antigen (HBsAg) kinetics after nucleos(t)ide analog (NA) discontinuation in patients with noncirrhotic chronic hepatitis B (CHB). The study specifically investigated long-term HBsAg ki
Externí odkaz:
https://doaj.org/article/415b38de27784d988b5083a1ef4ab88c
Publikováno v:
Non-coding RNA Research, Vol 9, Iss 4, Pp 1342-1350 (2024)
Background: The lack of effective non-invasive diagnostic methods for liver fibrosis hinders timely treatment for chronic hepatitis B (CHB) patients, leading to the progression of advanced liver disease. Circulating microRNAs offer a non-invasive app
Externí odkaz:
https://doaj.org/article/072542a9dd504f1d81f159c974d7fc74
Autor:
Alexia Paturel, Francesca Casuscelli di Tocco, Delphine Bousquet, Marie-Laure Plissonnier, Xavier Grand, Hyosun Tak, Françoise Berby, Caroline Scholtès, Barbara Testoni, Fabien Zoulim, Massimo Levrero
Publikováno v:
JHEP Reports, Vol 6, Iss 10, Pp 101124- (2024)
Background & Aims: Circulating HBV RNAs have been proposed as a biomarker that reflects the transcriptional activity of covalently closed circular DNA (cccDNA) and may help to evaluate HBV treatment activity. Different research assays have been propo
Externí odkaz:
https://doaj.org/article/df2fae496bcf4f019cadd2a168b5de9a
Autor:
Mohamed A Selim, Reda A. Suef, Ebrahim Saied, Mostafa A. Abdel-Maksoud, Saeedah Musaed Almutairi, Mohammed Aufy, Adel A. Mousa, Mohamed T. M. Mansour, Mohamed M. S. Farag
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundThe relationship between chronic hepatitis B (CHB) infection and natural killer (NK) cell dysfunction is well-established, but the specific role of HBV viral antigens in driving NK cell impairment in patients with CHB remains unclear. This
Externí odkaz:
https://doaj.org/article/1e6a6c9e51824783b44f684359d89dbe
Autor:
Mina Rahmati, Mojtaba Zare Ebrahimabad, Alale Langari, Ali Najafi, Shohreh Taziki, Alireza Norouzi, Mehrdad Teimoorian, Milad Khorasani, Saeed Mohammadi
Publikováno v:
Immuno, Vol 4, Iss 2, Pp 159-171 (2024)
Chronic hepatitis B (CHB) poses treatment challenges, with treatment response and disease outcome often determined by the immune response, particularly mononuclear phagocytes. Monocytes can differentiate into various subpopulations influenced by AHR.
Externí odkaz:
https://doaj.org/article/9347c79f21a94382972da35e101d24cd
Autor:
Jiancheng Huang, Mingkuan Su, Fanhui Kong, Hongbin Chen, Shuiqing Wu, Jianfeng Guo, Haiying Wu
Publikováno v:
Liver Research, Vol 8, Iss 1, Pp 54-60 (2024)
Background and aim: A genome-wide association study has indicated the association of numerous genes in the 6p21.3 region with chronic hepatitis B virus (HBV) infection. In this study, we screened 12 representative single-nucleotide polymorphisms (SNP
Externí odkaz:
https://doaj.org/article/e92a52a76e124bb4a52554c7fb7f58b0
Research progress of the impact of nonalcoholic fatty liver disease on chronic hepatitis B infection
Publikováno v:
Shanghai Jiaotong Daxue xuebao. Yixue ban, Vol 43, Iss 12, Pp 1585-1590 (2023)
Chronic hepatitis B (CHB) is an infectious disease caused by persistent infection with the hepatitis B virus (HBV) and is highly prevalent worldwide. Non-alcoholic fatty liver disease (NAFLD) is a group of liver diseases related to metabolic abnormal
Externí odkaz:
https://doaj.org/article/3999787c5a2842e69ec7a5fe5450127a
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundEvidence from observational studies suggests that chronic hepatitis B (CHB) is associated with cardiovascular disease (CVD). However, results have been inconsistent and causality remains to be established. We utilized two-sample Mendelian r
Externí odkaz:
https://doaj.org/article/20773f34ad6948229dea6f543d89a27d
Autor:
T. Uma Arasu, P. Kanchanadevi, A. Shajahan, Thirunavukkarasu Dharmalingam, Arbind Kumar Choudhary
Publikováno v:
Romanian Journal of Infectious Diseases, Vol 26, Iss 3, Pp 87-91 (2023)
Background. Hepatitis B virus (HBV) infection is a global health concern, with an estimated 296 million chronic carriers worldwide. Quantification of hepatitis B surface antigen (HBsAg) is a crucial tool in HBV disease management, providing valuable
Externí odkaz:
https://doaj.org/article/c7adfdf6353b4bf598d80a8f954470ae
Autor:
Li-Li Wu, Xiao-Yan Li, Kai Deng, Bing-Liang Lin, Hong Deng, Dong-Ying Xie, Geng-Lin Zhang, Qi-Yi Zhao, Zhi-Shuo Mo, Yue-Hua Huang, Zhi-Liang Gao
Publikováno v:
Liver Research, Vol 7, Iss 2, Pp 136-144 (2023)
Background and aims: The primary goal of chronic hepatitis B (CHB) treatment is to reduce hepatitis B surface antigen (HBsAg). T helper 17 (Th17) and regulatory T (Treg) cells are essential for the development of CHB. However, how Th17 and Treg cells
Externí odkaz:
https://doaj.org/article/8d959db95e01445fb794174860636754